SLC2A1 and idiopathic generalized epilepsy: Initially considered exceptionally rare, reports that SLC2A1 mutations account for ∼1% of idiopathic generalized epilepsies and the recognition of an expanding Glut1 DS phenotype suggest that there may be in excess of 11,000 individuals afflicted with the disorder in the US alone3, 4.